Lv2
128 积分 2023-09-17 加入
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
2个月前
已完结
Is PORTEC-4a the tipping point in endometrial cancer management?
2个月前
已完结
Chemoradiotherapy With or Without Simultaneous Integrated Boost for Cervical Cancer With Full-Thickness Stromal Invasion
4个月前
已完结
Which is the best timing to assess response after chemoradiation in locally advanced cervical cancer (BRILACC)?
4个月前
已完结
Application of Neoadjuvant Docetaxel Plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II Trial
7个月前
已完结
Radiotherapy With Cisplatin vs Carboplatin Paclitaxel for Head and Neck Squamous Cell Carcinoma
7个月前
已完结
皖公网安备34019202002308
